Royal Bank of Canada »

Athira Pharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Athira Pharma shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $0 67 0.00

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Athira Pharma

Perceptive Advisors
BML Capital Management
Vanguard Group
Simplify Asset Management
Propel Bio Management
Tang Capital Management
Renaissance Technologies
Acadian Asset Management
Pathstone Holdings
BlackRock
Citadel Advisors
Geode Capital Management
Susquehanna International
Two Sigma Advisers
State Street Corporation

View all funds holding Athira Pharma